Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 14, 2024

SELL
$0.8 - $15.88 $70,928 - $1.41 Million
-88,661 Reduced 82.85%
18,352 $14,000
Q3 2022

Nov 10, 2022

SELL
$0.8 - $15.88 $70,928 - $1.41 Million
-88,661 Reduced 82.85%
18,352 $0
Q2 2022

May 14, 2024

BUY
$1.18 - $2.04 $126,275 - $218,306
107,013 New
107,013 $183,000
Q2 2022

Aug 15, 2022

BUY
$1.18 - $2.04 $49,575 - $85,706
42,013 Added 64.64%
107,013 $183,000
Q1 2022

May 16, 2022

SELL
$1.34 - $2.26 $273,757 - $461,711
-204,297 Reduced 75.86%
65,000 $122,000
Q4 2021

Feb 14, 2022

SELL
$2.1 - $4.36 $560,987 - $1.16 Million
-267,137 Reduced 49.8%
269,297 $566,000
Q3 2021

Nov 10, 2021

BUY
$3.9 - $5.67 $2.09 Million - $3.04 Million
536,434 New
536,434 $2.18 Million

Others Institutions Holding AQB

About AquaBounty Technologies, Inc.


  • Ticker AQB
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Farm Products
  • Shares Outstandng 71,110,704
  • Market Cap $69.7M
  • Description
  • AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sel...
More about AQB
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.